216 related articles for article (PubMed ID: 22583405)
41. Ultrafine Angelica gigas powder normalizes ovarian hormone levels and has antiosteoporosis properties in ovariectomized rats: particle size effect.
Choi KO; Lee I; Paik SY; Kim DE; Lim JD; Kang WS; Ko S
J Med Food; 2012 Oct; 15(10):863-72. PubMed ID: 23039111
[TBL] [Abstract][Full Text] [Related]
42. Decursinol angelate: a cytotoxic and protein kinase C activating agent from the root of Angelica gigas.
Ahn KS; Sim WS; Lee IK; Seu YB; Kim IH
Planta Med; 1997 Aug; 63(4):360-1. PubMed ID: 9270380
[TBL] [Abstract][Full Text] [Related]
43. Bio- Fortification of
Azad MOK; Kang WS; Lim JD; Park CH
Pharmaceuticals (Basel); 2019 Dec; 13(1):. PubMed ID: 31881704
[No Abstract] [Full Text] [Related]
44. Biotransformation of plant secondary metabolite decursin by Mycobacterium sp. PYR1001.
Kim KY; Lee S; Cha CJ
J Agric Food Chem; 2010 Mar; 58(5):2931-4. PubMed ID: 20155945
[TBL] [Abstract][Full Text] [Related]
45. Angelica gigas Nakai extract-loaded fast-dissolving nanofiber based on poly(vinyl alcohol) and Soluplus for oral cancer therapy.
Nam S; Lee JJ; Lee SY; Jeong JY; Kang WS; Cho HJ
Int J Pharm; 2017 Jun; 526(1-2):225-234. PubMed ID: 28478278
[TBL] [Abstract][Full Text] [Related]
46. Absorption, distribution, metabolism, and excretion of decursin and decursinol angelate from Angelica gigas Nakai.
Kim KM; Kim MJ; Kang JS
J Microbiol Biotechnol; 2009 Dec; 19(12):1569-72. PubMed ID: 20075620
[TBL] [Abstract][Full Text] [Related]
47. Decursin and decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases.
Shehzad A; Parveen S; Qureshi M; Subhan F; Lee YS
Inflamm Res; 2018 Mar; 67(3):209-218. PubMed ID: 29134229
[TBL] [Abstract][Full Text] [Related]
48. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
49. Development and validation of an ultra-performance convergence chromatography method for the quality control of Angelica gigas Nakai.
Kim HS; Chun JM; Kwon BI; Lee AR; Kim HK; Lee AY
J Sep Sci; 2016 Oct; 39(20):4035-4041. PubMed ID: 27510737
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of cinnamate 4-hydroxylase gene enhances biosynthesis of decursinol angelate in Angelica gigas hairy roots.
Park NI; Park JH; Park SU
Mol Biotechnol; 2012 Feb; 50(2):114-20. PubMed ID: 21626264
[TBL] [Abstract][Full Text] [Related]
51. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase.
Son SH; Kim MJ; Chung WY; Son JA; Kim YS; Kim YC; Kang SS; Lee SK; Park KK
Cancer Lett; 2009 Jul; 280(1):86-92. PubMed ID: 19307054
[TBL] [Abstract][Full Text] [Related]
52. Development of Resveratrol-Loaded Herbal Extract-Based Nanocomposites and Their Application to the Therapy of Ovarian Cancer.
Nam S; Lee SY; Kang WS; Cho HJ
Nanomaterials (Basel); 2018 May; 8(6):. PubMed ID: 29857475
[TBL] [Abstract][Full Text] [Related]
53. First-pass metabolism of decursin, a bioactive compound of Angelica gigas, in rats.
Park HS; Kim B; Oh JH; Kim YC; Lee YJ
Planta Med; 2012 Jun; 78(9):909-13. PubMed ID: 22573368
[TBL] [Abstract][Full Text] [Related]
54. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas.
Ahn KS; Sim WS; Kim IH
Planta Med; 1996 Feb; 62(1):7-9. PubMed ID: 8720379
[TBL] [Abstract][Full Text] [Related]
55. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of beta-catenin.
Song GY; Lee JH; Cho M; Park BS; Kim DE; Oh S
Mol Pharmacol; 2007 Dec; 72(6):1599-606. PubMed ID: 17855653
[TBL] [Abstract][Full Text] [Related]
56. Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma.
Son SH; Park KK; Park SK; Kim YC; Kim YS; Lee SK; Chung WY
Phytother Res; 2011 Jul; 25(7):959-64. PubMed ID: 21170925
[TBL] [Abstract][Full Text] [Related]
57. Mechanism-based inactivation of cytochrome P450 2A6 by decursinol angelate isolated from Angelica Gigas.
Yoo HH; Lee MW; Kim YC; Yun CH; Kim DH
Drug Metab Dispos; 2007 Oct; 35(10):1759-65. PubMed ID: 17620343
[TBL] [Abstract][Full Text] [Related]
58. Optimized conditions for the extraction of secondary volatile metabolites in Angelica roots by accelerated solvent extraction.
Cho SK; Abd El-Aty AM; Choi JH; Kim MR; Shim JH
J Pharm Biomed Anal; 2007 Sep; 44(5):1154-8. PubMed ID: 17446029
[TBL] [Abstract][Full Text] [Related]
59. Comprehensive changes in volatile/nonvolatile compounds and flavor and physicochemical characteristics in Angelica gigas Nakai roots by thermal processing.
Kim DS; Kim HS; Lee J; Hong SJ; Cho JJ; Cho KM; Shin EC
J Food Biochem; 2019 Oct; 43(10):e12842. PubMed ID: 31608467
[TBL] [Abstract][Full Text] [Related]
60. Improvement in antiproliferative activity of Angelica gigas Nakai by solid dispersion formation via hot-melt extrusion and induction of cell cycle arrest and apoptosis in HeLa cells.
Jiang Y; Piao J; Cho HJ; Kang WS; Kim HY
Biosci Biotechnol Biochem; 2015; 79(10):1635-43. PubMed ID: 26057458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
